Literature DB >> 29907340

Roles of Aldolase Family Genes in Human Cancers and Diseases.

Yu-Chan Chang1, Yi-Chieh Yang2, Chia-Ping Tien3, Chih-Jen Yang4, Michael Hsiao5.   

Abstract

The aldolase family members involved in metabolism and glycolysis are present in three isoforms: ALDOA, ALDOB, and ALDOC. Aldolases are differentially expressed in human tissues, and aberrant expression has been observed in several human diseases and cancer types. However, non-enzymatic functions through protein-protein interactions or epigenetic modifications have been reported in recent years. Using high-throughput screening and -omics database integration, aldolase has been validated as an independent clinical prognostic marker of human cancers. Therefore, the aim of this review was to provide potential clinical value from in silico predictions and also summarize well-known signaling axes or phenotypes in various cancer types. Finally, we discuss the role of aldolase in the treatment of human diseases and cancers.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29907340     DOI: 10.1016/j.tem.2018.05.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  37 in total

1.  Computational and Experimental Studies of Inhibitor Design for Aldolase A.

Authors:  Rui Qi; Brandon Walker; Zhifeng Jing; Maiya Yu; Gabriel Stancu; Ramakrishna Edupuganti; Kevin N Dalby; Pengyu Ren
Journal:  J Phys Chem B       Date:  2019-07-03       Impact factor: 2.991

2.  Promoter Mutation Analysis of ALDOA Gene in Solid Tumors and Acute Leukemias.

Authors:  Hyun Ji Son; Eun Ji Choi; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2018-11-14       Impact factor: 3.201

Review 3.  Proteins moonlighting in tumor metabolism and epigenetics.

Authors:  Lei Lv; Qunying Lei
Journal:  Front Med       Date:  2021-01-02       Impact factor: 4.592

Review 4.  Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis.

Authors:  Chandra Prakash Prasad; Ajay Gogia; Atul Batra
Journal:  Clin Transl Oncol       Date:  2022-06-25       Impact factor: 3.340

5.  An IRF4-MYC-mTORC1 Integrated Pathway Controls Cell Growth and the Proliferative Capacity of Activated B Cells during B Cell Differentiation In Vivo.

Authors:  Dillon G Patterson; Anna K Kania; Madeline J Price; James R Rose; Christopher D Scharer; Jeremy M Boss
Journal:  J Immunol       Date:  2021-09-01       Impact factor: 5.426

6.  Phosphoproteomics Reveals Key Regulatory Kinases and Modulated Pathways Associated with Ovarian Cancer Tumors.

Authors:  Yingchao Hu; Lejia Sun; Yinglan Zhang; Jinghe Lang; Jun Rao
Journal:  Onco Targets Ther       Date:  2020-04-29       Impact factor: 4.147

Review 7.  Cancer microenvironment and genomics: evolution in process.

Authors:  Stanley P Leong; Isaac P Witz; Orit Sagi-Assif; Sivan Izraely; Jonathan Sleeman; Brian Piening; Bernard A Fox; Carlo B Bifulco; Rachel Martini; Lisa Newman; Melissa Davis; Lauren M Sanders; David Haussler; Olena M Vaske; Marlys Witte
Journal:  Clin Exp Metastasis       Date:  2021-05-10       Impact factor: 5.150

8.  High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma.

Authors:  Yan Tang; Xuefeng Yang; Kehai Feng; Changlu Hu; Suyi Li
Journal:  J Gastrointest Oncol       Date:  2021-02

9.  Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.

Authors:  Xiang Li; Chang Yu; Yichun Luo; Jiacheng Lin; Fang Wang; Xuehua Sun; Yueqiu Gao; Weifeng Tan; Qiang Xia; Xiaoni Kong
Journal:  Int J Biol Sci       Date:  2021-04-23       Impact factor: 6.580

10.  LncRNA ZNF674-AS1 regulates granulosa cell glycolysis and proliferation by interacting with ALDOA.

Authors:  Duan Li; Xiaoyan Wang; Guangyu Li; Yujie Dang; Shidou Zhao; Yingying Qin
Journal:  Cell Death Discov       Date:  2021-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.